Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle stem cells are promising for wound healing but require more research for safe clinical use.

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

Dermoscopy is useful for diagnosing hair loss patterns in dogs.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

The monkey's hair loss was due to an autoimmune disease, not genetics.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Human placental extract and minoxidil together significantly promote hair growth.

Misdiagnosis of LPP in AGA patients can cause hair transplant issues.

The conclusion is that teeth, hair, and claws have similar stem cell niches, which are important for growth and repair, and more research is needed on their regulation and potential markers.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

Alternative treatments show promise for hair growth beyond traditional methods.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

The document concludes that choosing the right biopsy site is crucial for accurate alopecia diagnosis, and combining methods can improve results.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

The study suggests that a new protease inhibitor can make hair harder to pull out, potentially reducing hair loss.

Wounds can regenerate hair in young mice, but this ability declines with age, offering insights for improving tissue regeneration in the elderly.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.